Antonio Gualberto
2018
In 2018, Antonio Gualberto earned a total compensation of $2M as Head of Development and Chief Medical Officer at Kura Oncology, a 61% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $215,800 |
|---|---|
| Option Awards | $1,379,760 |
| Salary | $415,000 |
| Other | $11,363 |
| Total | $2,021,923 |
Gualberto received $1.4M in option awards, accounting for 68% of the total pay in 2018.
Gualberto also received $215.8K in non-equity incentive plan, $415K in salary and $11.4K in other compensation.
Rankings
In 2018, Antonio Gualberto's compensation ranked 5,695th out of 14,244 executives tracked by ExecPay. In other words, Gualberto earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,695 out of 14,244 | 60th |
Division Manufacturing | 2,153 out of 5,759 | 63rd |
Major group Chemicals And Allied Products | 795 out of 2,122 | 63rd |
Industry group Drugs | 663 out of 1,811 | 63rd |
Industry Pharmaceutical Preparations | 512 out of 1,385 | 63rd |
Source: SEC filing on April 29, 2019.
Gualberto's colleagues
We found three more compensation records of executives who worked with Antonio Gualberto at Kura Oncology in 2018.